Russell Investments Group
BEAM icon

Russell Investments Group’s Beam Therapeutics BEAM Stock Holding History

Russell Investments Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37M Buy
156,585
+11,863
+8% +$358K ﹤0.01% 1458
2026
Q1 		$3.45M Buy
144,722
+122,594
+554% +$3.4M ﹤0.01% 1565
2025
Q4 		$613K Sell
22,128
-977
-4% -$24.9K ﹤0.01% 2415
2025
Q3 		$561K Buy
23,105
+8,181
+55% +$163K ﹤0.01% 2432
2025
Q2 		$254K Sell
14,924
-14,305
-49% -$249K ﹤0.01% 2579
2025
Q1 		$571K Sell
29,229
-146,952
-83% -$3.85M ﹤0.01% 2256
2024
Q4 		$4.37M Sell
176,181
-11,664
-6% -$298K 0.01% 1237
2024
Q3 		$4.6M Buy
187,845
+18,284
+11% +$472K 0.01% 1233
2024
Q2 		$3.97M Buy
169,561
+25,733
+18% +$632K 0.01% 1263
2024
Q1 		$4.75M Buy
143,828
+6,102
+4% +$190K 0.01% 1194
2023
Q4 		$3.75M Buy
137,726
+115
+0.1% +$2.86K 0.01% 1279
2023
Q3 		$3.31M Buy
137,611
+21,251
+18% +$570K 0.01% 1280
2023
Q2 		$3.72M Buy
116,360
+7,602
+7% +$247K 0.01% 1220
2023
Q1 		$3.33M Buy
108,758
+17,496
+19% +$690K 0.01% 1295
2022
Q4 		$3.57M Sell
91,262
-799
-0.9% -$35.8K 0.01% 1264
2022
Q3 		$4.38M Buy
92,061
+1,849
+2% +$105K 0.01% 1126
2022
Q2 		$3.49M Sell
90,212
-8
-0% -$318 0.01% 1280
2022
Q1 		$5.17M Buy
90,220
+894
+1% +$58.6K 0.01% 1139
2021
Q4 		$7.12M Buy
89,326
+18,303
+26% +$1.57M 0.01% 1066
2021
Q3 		$6.18M Buy
71,023
+10,106
+17% +$1.02M 0.01% 1128
2021
Q2 		$7.84M Buy
60,917
+33,537
+122% +$2.67M 0.01% 1067
2021
Q1 		$2.19M Buy
27,380
+21,565
+371% +$2.05M ﹤0.01% 1830
2020
Q4 		$474K Buy
+5,815
New +$286K ﹤0.01% 2453

Other funds holding BEAM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group's BEAM Position: Q2 2026 in Review

Russell Investments Group increased its Beam Therapeutics (BEAM) stake by 8.2% in Q2 2026, buying an estimated $358K and bringing the position to 156,585 shares worth $5.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Russell Investments Group first reported a position in BEAM in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.84M in Q2 2021. 116 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Russell Investments Group held 156,585 shares of Beam Therapeutics worth $5.37M as of Q2 2026.
  • Russell Investments Group bought 11,863 Beam Therapeutics shares in Q2 2026, an estimated $358K.
  • Beam Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1458 holding.
  • Russell Investments Group first reported a position in Beam Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Russell Investments Group's Beam Therapeutics position peaked at $7.84M in Q2 2021.
  • 116 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.